fda compounding glp-1 Hims & Hers stock falls 25% as curtails compounded GLP-1s New project announcement: HHS‑OIG is
Description
Multiple patient reviews specifically call this out as a differentiator
That meant no dangerous sugar crashes, a common problem with some older diabetes drugs
10.2337/dc14-1142 [DOI] [PubMed] [Google Scholar] 80.Mathieu C, Ranetti AE, Li D, Ekholm E, Cook W, Hirshberg B, et al
Designing a nutrition and activity plan to support weight management before and after discontinuation
The global market hit over $53 billion in 2024, and depending on which analyst report youre reading, projections suggest we could be looking at $165 billion by the early 2030s
